Literature DB >> 9292416

Inhibition of morphine tolerance and dependence by Withania somnifera in mice.

S K Kulkarni1, I Ninan.   

Abstract

Chronic treatment with Withania somnifera (Ws) (family: Solanaceae, 100 mg/kg) commercial root extract followed by saline on days 1-9 failed to produce any significant change in tailflick latency from the saline pretreated group in mice. However, repeated administration of Ws (100 mg/kg) for 9 days attenuated the development of tolerance to the analgesic effect of morphine (10 mg/kg). Ws (100 mg/kg) also suppressed morphine-withdrawal jumps, a sign of the development of dependence to opiate as assessed by naloxone (2 mg/kg) precipitation withdrawal on day 10 of testing.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9292416     DOI: 10.1016/s0378-8741(97)00064-0

Source DB:  PubMed          Journal:  J Ethnopharmacol        ISSN: 0378-8741            Impact factor:   4.360


  9 in total

1.  Withania somnifera prevents morphine withdrawal-induced decrease in spine density in nucleus accumbens shell of rats: a confocal laser scanning microscopy study.

Authors:  Sanjay Kasture; Stefania Vinci; Federico Ibba; Alessandro Puddu; Mara Marongiu; Balasubramanian Murali; Augusta Pisanu; Daniele Lecca; Gerald Zernig; Elio Acquas
Journal:  Neurotox Res       Date:  2009-06-24       Impact factor: 3.911

2.  Plants with Anti-Addictive Potential.

Authors:  Eduardo Luis Konrath; Marcelo Dutra Arbo; Bruno Dutra Arbo; Mariana Appel Hort; Elaine Elisabetsky; Mirna Bainy Leal
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

3.  Antihyperalgesic effects of ashwagandha (Withania somnifera root extract) in rat models of postoperative and neuropathic pain.

Authors:  Dong Wook Lim; Jae Goo Kim; Eun Yeong Lim; Yun Tai Kim
Journal:  Inflammopharmacology       Date:  2017-08-28       Impact factor: 4.473

4.  Foliar application of elicitors enhanced the yield of withanolide contents in Withania somnifera (L.) Dunal (variety, Poshita).

Authors:  Manali Singh; Nitesh Kumar Poddar; Dipti Singh; Sanjeev Agrawal
Journal:  3 Biotech       Date:  2020-03-04       Impact factor: 2.406

5.  Alleviation of Morphine Withdrawal Signs but Not Tolerance by the Essential Oil of Kelussia odoratissima Mozaff.

Authors:  Mohammed Rabbani; Seyed Ebrahim Sajjadi; Azadeh Izadi
Journal:  Evid Based Complement Alternat Med       Date:  2012-07-05       Impact factor: 2.629

6.  The standardized Withania somnifera Dunal root extract alters basal and morphine-induced opioid receptor gene expression changes in neuroblastoma cells.

Authors:  Francesca Felicia Caputi; Elio Acquas; Sanjay Kasture; Stefania Ruiu; Sanzio Candeletti; Patrizia Romualdi
Journal:  BMC Complement Altern Med       Date:  2018-01-10       Impact factor: 3.659

7.  Triethylene glycol-like effects of Ashwagandha (Withania somnifera (L.) Dunal) root extract devoid of withanolides in stressed mice.

Authors:  Amitabha Dey; Shyam Sunder Chatterjee; Vikas Kumar
Journal:  Ayu       Date:  2018 Oct-Dec

8.  Effects of docosanyl ferulate, a constituent of Withania somnifera, on ethanol- and morphine-elicited conditioned place preference and ERK phosphorylation in the accumbens shell of CD1 mice.

Authors:  Riccardo Maccioni; Marcello Serra; Jacopo Marongiu; Filippo Cottiglia; Elias Maccioni; Valentina Bassareo; Micaela Morelli; Sanjay B Kasture; Elio Acquas
Journal:  Psychopharmacology (Berl)       Date:  2022-01-28       Impact factor: 4.530

9.  Effect of Withania somnifera (L.) Dunal on Sex Hormone and Gonadotropin Levels in Addicted Male Rats.

Authors:  Batool Rahmati; Mohammad Hassan Ghosian Moghaddam; Mohsen Khalili; Ehsan Enayati; Maryam Maleki; Saeedeh Rezaeei
Journal:  Int J Fertil Steril       Date:  2016-06-01
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.